Your browser doesn't support javascript.
loading
LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
Vranckx, Lenard S; Demeulemeester, Jonas; Saleh, Suha; Boll, Annegret; Vansant, Gerlinde; Schrijvers, Rik; Weydert, Caroline; Battivelli, Emilie; Verdin, Eric; Cereseto, Anna; Christ, Frauke; Gijsbers, Rik; Debyser, Zeger.
Affiliation
  • Vranckx LS; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Lenard.vranckx@med.kuleuven.be.
  • Demeulemeester J; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Jonas.Demeulemeester@med.kuleuven.be.
  • Saleh S; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: suha.saleh@kuleuven.be.
  • Boll A; Laboratory of Molecular Virology, Centre for Integrative Biology (CIBIO), University of Trento, Via delle Regole 101, 38123 Trento, Italy. Electronic address: annegret.boll@gmail.com.
  • Vansant G; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Gerlinde.vansant@kuleuven.be.
  • Schrijvers R; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Herestraat 49, 3000 Leuven, Fla
  • Weydert C; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Caroline.weydert@med.kuleuven.be.
  • Battivelli E; Gladstone Institute of Virology and Immunology, University of California, 1650 Owens St., 94158 San Francisco, CA, USA. Electronic address: emilie.battivelli@gladstone.ucsf.edu.
  • Verdin E; Gladstone Institute of Virology and Immunology, University of California, 1650 Owens St., 94158 San Francisco, CA, USA. Electronic address: eric.verdin@gladstone.ucsf.edu.
  • Cereseto A; Laboratory of Molecular Virology, Centre for Integrative Biology (CIBIO), University of Trento, Via delle Regole 101, 38123 Trento, Italy. Electronic address: anna.cereseto@unitn.it.
  • Christ F; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Frauke.Christ@med.kuleuven.be.
  • Gijsbers R; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Rik.Gijsbers@med.kuleuven.be.
  • Debyser Z; Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Kapucijnenvoer 33 VTCB +5, 3000 Leuven, Flanders, Belgium. Electronic address: Zeger.debyser@med.kuleuven.be.
EBioMedicine ; 8: 248-264, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27428435

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / HIV Infections / HIV-1 / Virus Latency / HIV Integrase Inhibitors / HIV Integrase / Adaptor Proteins, Signal Transducing Limits: Humans Language: En Journal: EBioMedicine Year: 2016 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / HIV Infections / HIV-1 / Virus Latency / HIV Integrase Inhibitors / HIV Integrase / Adaptor Proteins, Signal Transducing Limits: Humans Language: En Journal: EBioMedicine Year: 2016 Document type: Article Country of publication: Netherlands